Clinical Trial Update: Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA [Phase 2]

View source ↗

Summary

Phase 2 COSIRA trial evaluated the Coronary Sinus Reducer for treatment of refractory angina; the study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina

Drugs mentioned

• Coronary Sinus Reducer

Snippet

Sponsor: Shockwave Medical, Inc. | Conditions: Refractory Angina | Phase 2 | Status: COMPLETED